Stereoselective synthesis of α-aminophosphonic acids analogs of the 20 proteinogenic α-amino acids

Current Organic Synthesis

Volumn 9, Issue 3, 2012, Pages 310-341

  Ordóñez, Mario ^a   Viveros Ceballos, José Luis ^a   Cativiela, Carlos ^b   Arizpe, Alicia ^b  

^a CENTRO DE INVESTIGACIONES QUÍMICAS   (Mexico)

^b CSIC   (Spain)

Author keywords

Biological activity; Resolution; Stereoselective synthesis; amino acids; aminophosphonates; Aminophosphonic acids

Indexed keywords

EID: 84861163776     PISSN: 15701794     EISSN: None     Source Type: Journal    
DOI: 10.2174/157017912801270595     Document Type: Review

References (246)

1. Sieαczyk, M.; Oleksyszyn, J. Irreversible inhibition of serine proteasesdesign and in vivo activity of diaryl α-aminophosphonate derivatives. Curr. Med. Chem. 2009, 16, 1673-1687.
2. Aminophosphonic and Aminophosphinic Acids. Chemistry and Biological Activity; Kukhar, V. P.; Hudson, H. R., Eds.; John Wiley & Sons: Chichester, UK, 2000.
3. Kafarski, P.; Lejczak, B. Biological activity of aminophosphonic acids. βPhosphorus, Sulfur Silicon Relat. Elem. 1991, 63, 193-215.
4. Dhawan, B.; Redmore, D. Optically active 1-aminoalkylphosphonic acids. Phosphorus Sulfur 1987, 32, 119-144.
5. Rozenfeld, R.; Iturrioz, X.; Okada, M.; Maigret, B.; Llorents-Cortes, C. Contribution of molecular modeling and site-directed mutagenesis to the identification of a new residue, glutamate 215, involve in the exopeptidase specificity of aminopeptidase A. Biochemistry 2003, 42, 14785-14793.
6. Hirschmann, R.; Yager, K. M.; Taylor, C. M.; Witherington, J.; Sprengler, P. A.; Phillips, B. W.; Moore, W.; Smith, III, A. B. Phosphonate diester and phosphonamide synthesis. Reaction coordinate analysis by 31P NMR spectroscopy: identification of pyrophosphonate anhydrides and highly reactive phosphonylammonium salts. J. Am. Chem. Soc. 1997, 119, 8177-8190.
7. Hirschmann, R.; Smith, III, A. B.; Taylor, C. M.; Benkovic, P. A.; Taylor, S. D.; Yager, K. M.; Sprengler, P. A.; Benkovic, S. J. Peptide synthesis catalyzed by an antibody containing a binding site for variable amino acids. Science 1994, 265, 234-237.
8. Oleksyszyn, J.; Powers, J. C. Irreversible inhibition of serine proteases by peptide derivatives of (α-aminoalkyl)phosphonate diphenyl esters. Biochemistry 1991, 30, 485-493.
9. Allen, M. C.; Fuhrer, W.; Tuck, B.; Wade, R.; Wood, J. M. Renin inhibitors. Synthesis of transition-state analog inhibitors containing phosphorus acid derivatives at the scissile bond. J. Med. Chem. 1989, 32, 1652-1661.
10. Giannousis, P. P.; Bartlett, P. A. Phosphorus amino acid analogues as inhibitors of leucine aminopeptidase. J. Med. Chem. 1987, 30, 1603-1609.
11. For some examples on the synthesis of phosphono-peptides see Senten, K.; Daniëls, L.; Van der Veken, P.; De Meester, I.; Lambeir, A.-M.; Scharpé, S.; Haemers, A.; Augustyns, K. Rapid parallel synthesis of dipeptide diphenyl phosphonate esters as inhibitors of dipeptidyl peptidases. J. Comb. Chem. 2003, 5, 336-344.
12. Senten, K.; Van der Veken, P.; Bal. G.; Hae mers, A.; Augustyns, K. Polymer-assisted solution-phase parallel synthesis of dipeptide p-nitroanilides and dipeptide diphenyl phosphonates. Tetrahedron Lett. 2001, 42, 9135-9138.
13. Sikora, D.; Nonas, T.; Gajda, T. OEthyl 1-azidoalkylphosphonic acids-versatile reagents for the synthesis of protected phosphonamidate peptides. Tetrahedron 2001, 57, 1619-1625.
14. Cambell, D. A.; Bermak, J. C. Solid-phase synthesis of peptidylphosphonates. J. Am. Chem. Soc. 1994, 116, 6039-6040.
15. Sampson, N. S.; Batlett, P. A. Synthesis of phosphonic acid derivatives by oxidative activation of phosphinate esters. J. Org. Chem. 1988, 53, 4500-4503.
16. Atherton, F. R.; Hall, M. J.; Hassall, C. H.; Lambert, R. W.; Lloyd, W. J.; Lord, A. V.; Ringrose, P. S.; Westmacott, D. Phosphonopeptides as substrates for peptide transport systems and peptidases of Escherichia coli. Antimicrob. Agents Chemother. 1983, 24, 522-528.
17. Atherton, F. R.; Hall, M. J.; Hassall, C. H.; Lambert, R. W.; Lloyd, W. J.; Ringrose, P. S.; Westmacott, D. Antibacterial activity and mechanism of action of phosphonopeptides based on aminomethylphosphonic acid. Antimicrob. Agents Chemother. 1982, 22, 571-578.
18. Kametani, T.; Kigasawa, K.; Hiiragi, M.; Wakisaka, K.; Haga, S.; Sugi, H.; Tanigawa, K.; Suzuki, Y.; Fukawa, K.; Irino, O.; Saita, O.; Yamabe, S. Studies on the synthesis of chemotherapeutics. Part XI. Synthesis and antibacterial activities of phosphono-peptides. Heterocycles 1981, 16, 1205-1241.
19. Alonso, E.; Solis, A.; del Pozo, C. Synthesis of N-alkyl-(α-aminoalkyl)phosphine oxides and phosphonic esters as potential HIVprotease inhibitors, starting from α-aminoacids. Synlett 2000, 698-700.
20. 2-symmetry. Tetrahedron Lett. 1992, 33, 6625-6628.
21. Camp, N. P.; Hawkins, P. C. D.; Hitchcock, P. B.; Gani, D. Synthesis of stereochemically defined phosphonamidate-containing peptides: inhibitors for the HIV-1 proteinase. Bioorg. Med. Chem. Lett. 1992, 2, 1047-1052.
22. Allen, J. G.; Atherton, F. R.; Hall, M. J.; Hassall, C. H.; Holmes, S. W.; Lambert, R. W.; Nisbet, L. J.; Ringrose, P. S. Phosphonopeptides, a new class of synthetic antibacterial agents. Nature 1978, 272, 56-58.
23. Atherton, F. R.; Hassall, C. H.; Lambert, R. W. Synthesis and structure-activity relationships of antibacterial phosphonopeptides incorporating (1-aminoethyl)phosphonic acid and (aminomethyl)phosphonic acid. J. Med. Chem. 1986, 29, 29-40.
24. Lejczak, B.; Kafarski, P.; Sztajer, H.; Mastalerz, P. Antibacterial activity of phosphonodipeptides related to alafosfalin. J. Med. Chem. 1986, 29, 2212-2217.
25. Feng, Y.; Coward, J. K. Prodrug forms of N-[(4-deoxy-4-amino-10-methyl)pteroyl]glutamate-γ-[ωP(O)(OH)]-glutarate, a potent inhibitor of folypoly-γ-glutamate synthetase: synthesis and hydrolytic stability. J. Med. Chem. 2006, 49, 770-788.
26. Kafarski, P.; Lejczak, B. Aminophosphonic acids of potential medical importance. Curr. Med. Chem. 2001, 1, 301-312.
27. Lavielle, G.; Hautefaye, P.; Schaeffer, C.; Boutin, J. A.; Cudennec, C. A.; Pierré, A. New α-aminophosphonic acid derivatives of vinblastine: chemistry and antitumor activity. J. Med. Chem. 1991, 34, 1998-2003.
28. Huang, J.; Chen, R. An overview of recent advances on the synthesis and biological activity of α-aminophosphonic acid derivatives. Heteroatom. Chem. 2000, 11, 480-492.
29. Maier, L.; Diel, P. J. Organic phosphorus compounds: preparation, physical and biological properties of aminoarylmethylphosphonic and phosphonous acids. Phosphorus, Sulfur Silicon Relat. Elem. 1991, 57, 57-64.
30. Kozlowski, H.; Pusino, A.; Swiatek, J.; Spychala, J.; Glowiak, T.; Micera, G.; Gessa, C. Binding ability of pesticides. X-ray, spectroscopic, and polarographic studies of the copper (II) interaction with acifluorfen. J. Agric. Food Chem. 1990, 38, 1989-1992.
31. Nska, H.; Bonarska, D.; Bielecki, K.; Sarapuk, J. Antioxidative activity of some phenoxy and organophosphorous compounds. Cell. Mol. Biol. Lett. 2002, 7, 929-935.
32. Jagodic, V.; Herak, M. J. Synthesis and properties of a novel aminophosphonic acid as an extracting agent for metals. J. Inorg. Nucl. Chem. 1970, 32, 1323-1332.
33. Bligh, S. W. A.; Choi, N.; Green, D. St. C.; Hudson, H. R.; McGrath, C. M.; McPartlin, M.; Pianka, M. Transition metal complexes of dialkyl α-hydroxyiminophosphonates, a novel class of metal complexes. Polyhedron 1993, 12, 2887-2890 and references cited therein.
34. Bulman, R. A. In Trace Metals and Fluoride in Bones and Teeth, Priest, N. O.; Van de Vyver, F. L. Eds., CRC Press: Boca Raton, FL, 1990; p. 271.
35. Engel, R. Phosphonates as analogues of natural phosphates. Chem. Rev. 1977, 77, 349-367.
36. Ordóñez, M.; Rojas-Cabrera, H.; Cativiela, C. An overview of stereoselective synthesis of α-aminophosphonic acids and derivatives. Tetrahedron 2009, 65, 17-49.
37. Bhadury, P. S.; Song, B.-A.; Yang, S.; Zhang, Y.; Zhang, S. Some potential chiral catalysts for preparation of asymmetric α-aminophosphonates. Curr. Org. Synth. 2008, 5, 134-150.
38. Merino, P.; Marqués-López, E.; Herrera, R. P. Catalytic enantioselective hydrophosphonylation of aldehydes and imines. Adv. Synth. Catal. 2008, 350, 1195-1208.
39. Ma, J.-A. Catalytic asymmetric synthesis of α-and α-aminoalkanephosphonic acid derivatives. Chem. Soc. Rev. 2006, 35, 630-636.
40. Uziel, J.; Genêt, J. P. Synthesis of racemic and optically active α-aminophosphonic acids. Russ. J. Org. Chem. 1997, 33, 1521-1542.
41. Kukhar, V. P.; Soloshonok, V. A.; Solodenko, V. A. Asymmetric synthesis of phosphorus analogs of amino acids. Phosphorus, Sulfur Silicon Relat. Elem. 1994, 92, 239-264.
42. Drag, M.; Pawelczak, M.; Kafarski, P. Stereoselective synthesis of 1-aminoalkanephosphonic acids with two chiral centers and their activity towards leucine aminopeptidase. Chirality 2003, 15, S104-S107.
43. Baylis, E. K.; Campbell, C. D.; Dingwall, J. G. 1-Aminoalkylphosphonous acids. Part 1. Isosteres of the protein amino acids. J. Chem. Soc., Perkin Trans 1 1984, 2845-2853.
44. Atherton, F. R.; Hall, M. J.; Hassall, C. H.; Lambert, R. W.; Lloyd, W. J.; Ringrose, P. S. Phosphonopeptides as antibacterial agents: mechanism of action of alaphosphin. Antimicrob. Agents Chemother. 1979, 15, 696-705.
45. Tu, M.; Hurd, C.; Robinson, R.; Randall, J. M. Glyphosate, weed control methods. Handbook. Nat. Conservancy 2001, 11, 123-144.
46. Deron, A.; Dziamska, A.; Pawlaczyk, I.; Bielecki, K.; Kleszczyska, H.; Gancarz, R.; Sarapuk, J. The membrane-disrupting activity of α-aminoalkanephosphonic acids and their derivatives. Cell. Mol. Biol. Lett. 2001, 6, 291-297 and references cited therein.
47. Reddy, K. N.; Rimando, A. M.; Duke, S. O.; Nandula, V. K. Aminomethylphosphonic acid accumulation in plant species trated with glyphosate. J. Agric. Food Chem. 2008, 56, 2125-2130.
48. Duke, S. O.; Rimando, A. M.; Pace, P. F.; Reddy, K. N.; Smeda, R. J. Isoflavone, glyphosate, and aminomethyl-phosphonic acid levels in seeds of glyphosate-treated, glyphosateresistant soybean. J. Agric. Food Chem. 2003, 51, 340-344.
49. Kudzin, Z. H.; Gralak, D. K.; Adrijewski, G.; Drabowicz, J.; Uczak, J. Simultaneous analysis of biologically active aminoalkanephosphonic acids. J. Chromatogr. A 2003, 998, 183-199 and references cited therein.
50. De Lombaert, S.; Blanchard, L.; Stamford, L. B.; Tan, J.; Wallace, E. M.; Satoh, Y.; Fitt, J.; Hoyer, D.; Simonsbergen, D.; Moliterni, J.; Marcopoulos, N.; Savage, P.; Chou, M.; Trapani, A. J.; Jeng, A. Y. Potent and selective nonpeptidic inhibitors of endothelin-converting enzyme-1 with sustained duration of action. J. Med. Chem. 2000, 43, 488-504.
51. Hirschmann, R.; Yager, K. M.; Taylor, C. M.; Witherington, J.; Sprengler, P. A.; Phillips, B. W.; Moore, W.; Smith, III, A. B. Phosphonate diester and phosphonamide synthesis. Reaction coordinate analysis by 31P NMR spectroscopy: identification of pyrophosphonate anhydrides and highly reactive phosphonylammonium salts. J. Am. Chem. Soc. 1997, 119, 8177-8190.
52. Yamauchi, K.; Mitsuda, Y.; Kinoshita, M. Peptides containing aminophosphonic acids 3. Synthesis of tripeptide containing aminomethylphosphonic acid. Bull. Chem. Soc. Jpn. 1975, 48, 3285-3286.
53. Yamauchi, K.; Kinoshita, M.; Imoto, M. Peptides containing aminophosphonic acids II. The synthesis of tripeptide analogs. Bull. Chem. Soc. Jpn. 1972, 45, 2531-2534.
54. Rahil, J.; Pratt, F. R. Characterization of covalently bound enzyme inhibitors as transition-state analogs by protein stability measurements: phosphonate monoester inhibitors of β-lactamase. Biochemistry 1994, 33, 116-125.
55. Rahil, J.; Pratt R. F. Structure-activity relationships in the inhibition of serine β-lactamases by phosphonic acid derivatives. Biochem. J. 1993, 296, 389-393.
56. Pratt, R. F. Inhibition of a class C β-lactamase by a specific phosphonate monoester. Science 1989, 246, 917-919.
57. Bartlett, P. A.; Marlowe, C. K. Possible role for water dissociation in the slow binding of phosphorus-containing transition-state-analog inhibitors of thermolysin. Biochemistry 1987, 26, 8553-8561.
58. Payne, D. J.; Bateson, J. H.; Tolson, D. A.; Gasson, B. C.; Khushi, T.; Ledent, P.; Fere, J. M. Phosphonamidate analogues of dipeptides with carboxypeptidase A and β-lactamase-inhibitory activity: elucidation of the mechanism of β-lactamase inhibition by electrospray mass spectrometry. Biochem. J. 1996, 314, 457-461.
59. Bateson, J. H.; Gasson, B. C.; Khushi, T.; Neale, J. E.; Payne D. J.; Tolson, D. A.; Walker, G. The synthesis and serine β-lactamase inhibitory activity of some phosphonamidate analogues of dipeptides. Bioorg. Med. Chem. Lett. 1994, 4, 1667-1672.
60. Li, N.; Rahil, J.; Wright, M. E.; Pratt, R. F. Structure-activity studies of the inhibition of serine β-lactamases by phosphonate monoesters. Bioorg. Med. Chem. 1997, 5, 1783-1788.
61. Engelmann, M.; Pilk, J. Organic compound and process of preparing the same. U. S. Patent 2304156, 1942.
62. Pilk, J. Organic compound and process for preparing the same. U. S. Patent 2328358, 1943.
63. Soroka, M. Comments on the synthesis of aminomethylphosphonic acid. Synthesis 1989, 547-548.
64. Pulwer, M. J.; Balthazor, T. M. A convenient synthesis of aminomethylphosphonic acid. Synth. Commun. 1986, 16, 733-739.
65. Oleksyszyn, J.; Subotkowska, L. Aminomethanephosphonic acid and its diphenyl ester. Synthesis 1980, 906-906.
66. Ratcliffe, R. W.; Christensen, B. G. Total synthesis of β-lactam antibiotics I. α-thioformamido-diethylphosphonoacetates. Tetrahedron Lett. 1973, 14, 4645-4648.
67. For the synthesis of diethyl phosphonomethyl-triflate, see: Creary, X.; Underiner, T. L. Stabilization demands of diethyl phosphonate substituted carbocations as revealed by substituent effects. J. Org. Chem. 1985, 50, 2165-2170.
68. Phillion, D. P.; Andrew, S. S. Synthesis and reactivity of diethyl phosphonomethyltriflate. Tetrahedron Lett. 1986, 27, 1477-1480.
69. Soroka, M.; Jaworska, D.; Szczsny, Z. Synthesis of 1-aminoalkylphosphonic acids via amidoalkylation of phosphorous acid by N, N'-alkylidenebisamides. Liebigs Ann. Chem. 1990, 1153-1155.
70. Soroka, M. The synthesis of 1-aminoalkylphosphonic acids. A revised mechanism of the reaction of phosphorus trichloride, amides and aldehydes or ketones in acetic acid (Oleksyszyn reaction). Liebigs Ann. Chem. 1990, 331-334.
71. For the biological activity of (S, R)-alafosfalin, see: Neumann, J.; Bruch, M.; Gebauer, S.; Brandsch, M. Transport of the phosphonodipeptide alafosfalin by the H+/peptide cotransporters PEPT1 and PEPT2 in intestinal and renal epithelial cells. Eur. J. Biochem. 2004, 271, 2012-2017.
72. Perry, J. D.; Riley, G.; Gould, F. K.; Perez, J. M.; Boissier, E.; Ouedraogo, R. T.; Freydière, A. M. Alafosfalin as a selective agent for isolation of salmonella from clinical samples. J. Clin. Microbiol. 2002, 40, 3913-3916.
73. Atherton, F. R.; Hall, M. J.; Hassall, C. H.; Lambert, R. W.; Lloyd, W. J.; Ringrose, P. S. Phosphonopeptide antibacterial agents related to alafosfalin: design, synthesis, and structure-activity relationships. Antimicrob. Agents Chemother. 1980, 18, 897-905.
74. Coeffard, V.; Beaudet, I.; Evain, M.; Grognec, E. L.; Quintard, J.-P. Preparation and transmetallation of enantioenriched α-aminoorganostannanes derived from N-Boc phenylglycinol: application to the synthesis of alafosfalin. Eur. J. Org. Chem. 2008, 3344-3351.
75. Khomutov, R. M.; Osipova, T. I.; Khurs, E. N.; Dzhavakhiya, V. G. Synthesis of alafosfalin and its phosphinic analogue and their fungicidal activity. Mendeleev Commun. 2008, 18, 295-296.
76. Solodenko, V.; Kasheva, T.; Kukhar, V. P. Preparation of N-acylated phosphonopeptides with free phosphonic group. Synth. Commun. 1991, 21, 1631-1641.
77. Solodenko, V. A.; Kukhar, V. P. Stereoselective papain-catalyzed synthesis of alafosfalin. Tetrahedron Lett. 1989, 30, 6917-6918.
78. Kafarski, P.; Lejzak, B.; Mastalerz, P.; Szewczyk, J.; Wasielewski, C. Phosphonodipeptides: synthesis and separation of diastereoisomers. Can. J. Chem. 1982, 60, 3081-3084.
79. Huber, III, J. W.; Gilmore, W. F. Synthesis and antimicrobial evaluation of N-D-alanyl-1-aminoethylphosphonic acid. J. Med. Chem. 1975, 18, 106-108.
80. Copie, V.; Faraci, W. S.; Walsh, C. T.; Griffin, R. G. Inhibition of alanine racemase by alanine phosphonate: detection of an imine linkage to pyridoxal 5'-phosphate in the enzyme-inhibitor complex by solid-state nitrogen-15 nuclear magnetic resonance. Biochemistry 1988, 27, 4966-4970.
81. Allen, J. G.; Atherton, F. R.; Hall, M. J.; Hassall, C. H.; Holmes, S. W.; Lambert, R. W.; Nisbet, L. J.; Ringrose, P. S. Phosphonopeptides, a new class of synthetic antibacterial agents. Nature 1978, 272, 56-58.
82. Atherton, F. R.; Hassall, C. H.; Lambert, R. W. Synthesis and structureactivity relationships of antibacterial phosphonopeptides incorporating (1-aminoethyl)phosphonic acid and (aminomethyl)phosphonic acid. J. Med. Chem. 1986, 29, 29-40.
83. Atherton, F. R.; Hall, M. J.; Hassall, C. H.; Lambert, R. W.; Lloyd, W. J.; Ringrose, P. S. Phosphonopeptides as antibacterial agents: mechanism of action of alaphosphin. Antimicrob. Agents Chemother. 1979, 15, 696-705.
84. Allen, J. G.; Atherton, F. R.; Hall, M. J.; Hassall, C. H.; Holmes, S. W.; Lambert, R. W.; Nisbet, L. J.; Ringrose, P. S. Phosphonopeptides as antibacterial agents: alaphosphin and related phosphonopeptides. Antimicrob. Agents Chemother. 1979, 15, 684-695.
85. Winum, J.-Y.; Bouissière, J.-L.; Passagne, I.; Evrard, A.; Montero, V.; Cuq, P.; Montero, J.-L. Synthesis and biological evaluation of fotemustine analogues on human melanoma cell lines. Eur. J. Med. Chem. 2003, 38, 319-324.
86. Falkson, C. I.; Falkson, G.; Falkson, H. C. Phase II trial of fotemustine in patients with metastatic malignant melanoma. Invest. News Drugs 1994, 12, 251-254.
87. Brakenhoff, J. P. G.; Commandeur, J. N. M.; Wormhoudt, L. W.; Groot, E. J.; Vermeulen, N. P. E. Molecular mechanisms of toxic effects of fotemustine in rat hepatocytes and subcellular rat liver fractions. Carcinogenesis 1996, 17, 715-724.
88. Iliadis, A.; Launay-Iliadis, M.-C.; Lucas, C.; Fety, R.; Lokiec, F.; Tranchand, B.; Milano, G. Pharmacokinetics and pharmacodynamics of nitrosourea fotemustine: a French cancer centre multicentric study. Eur. J. Cancer 1996, 32A, 455-460.
89. Liu, W.; Rogers, C. J.; Fisher, A. J.; Toney, M. D. Aminophosphonate inhibitors of dialkylglycine decarboxylase: structural basis for slow binding inhibition. Biochemistry 2002, 41, 12320-12328.
90. Badet, B.; Walsh, C. Purification of an alanine racemase from Streptococcus faecalis and analysis of its inactivation by (1-aminoethyl)phosphonic acid enantiomers. Biochemistry 1985, 24, 1333-1341.
91. Auberson, Y. P.; Allgeier, H.; Bischoff, S.; Lingenhoehl, K.; Moretti, R.; Schmutz, M. 5-Phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition. Bioorg. Med. Chem. Lett. 2002, 12, 1099-1102.
92. Auberson, Y. P.; Acklin, P.; Bischoff, S.; Moretti, R.; Ofner, S.; Schmutz, M.; Veenstra, S. J. N-phosphonoalkyl-5-aminomethylquinoxaline-2,3-diones: In vivo active AMPA and NMDA (glycine) antagonists. Bioorg. Med. Chem. 1999, 9, 249-254.
93. Verdier-Pinard, P.; Garès, M.; Wright, M. Differential in vitro association of vinca alkaloid-induced tubulin spiral filaments into aggregated spirals. Biochem. Pharmacol. 1999, 58, 959-971.
94. Huber, R.; Knierzinger, A.; Obrecht, J.-P.; Vasella, A. Nucleophilic additions to N-glycosylnitrones: asymmetric synthesis of α-aminophosphonic acids. Helv. Chim. Acta 1985, 68, 1730-1747.
95. Oshikawa, T.; Yamashita, M. Preparation of optically active 1-aminoalkylphosphonic acids from chiral carbamates and chiral ureas. Bull. Chem. Soc. Jpn. 1989, 62, 3177-3181.
96. Maury, C.; Gharbaoui, T.; Royer, J.; Husson, H.-P. Asymmetric synthesis of α-aminophosphonic acids by diastereoselective addition of trimethyl phosphite onto chiral oxazolidines. J. Org. Chem. 1996, 61, 3687-3693.
97. Schöllkopf, U.; Schütze, R. Asymmetrische synthese von (S)-(1-aminoalkyl)phosphonsäure-diethylestern unter verwendung von (+)-campher als chiralem hilfsreagens. Liebigs Ann. Chem. 1987, 45-49.
98. Maury, C.; Royer, J.; Husson, H.-P. A simple and general method for the asymmetric synthesis of α-aminophosphonic acids. Tetrahedron Lett. 1992, 33, 6127-6130.
99. Hanessian, S.; Bennani, Y. L. A versatile asymmetric synthesis of α-amino α-alkylphosphonic acids of high enantiomeric purity. Tetrahedron Lett. 1990, 31, 6465-6468.
100. Yuan, C.-Y.; Chen, Q.-Y. Facile and efficient asymmetric synthesis of α-aminoalkylphosphonic acids. Chin. J. Chem. 2005, 23, 1671-1676.
101. Yuan, C.-Y.; Li, J. X.; Cui, S.; Wang, G. Asymmetric synthesis of aminophosphonic acids and trifluoromethylated derivatives thereof. Phosphorus Sulfur 2002, 177, 1731-1734.
102. Gololobov, Y. G.; Kasukhin, L. F. Recent advances in the Staudinger reaction. Tetrahedron 1992, 48, 1353-1406.
103. Tian, W. Q.; Wang, Y. A. Mechanisms of Staudinger reactions within density functional theory. J. Org. Chem. 2004, 69, 4299-4308 and references cited therein.
104. Yuan, C.; Li, S.; Wang, G. A new and efficient asymmetric synthesis of 1-amino-1-alkylphosphonic acids. Heteroatom. Chem. 2000, 11, 528-535.
105. Sting, M.; Steglich, W. Phosphoranalogue von aminosäuren III. Synthese optisch aktiver 1-aminoalkylphosphonsäuren der (S)-und (R)-reihe mit hilfe von (-)-ephedrin als auxiliar. Synthesis 1990, 132-134.
106. Hanessian, S.; Bennani, Y. F. Electrophilic amination and azidation of chiral α-alkyl phosphonamides: asymmetric syntheses of α-amino α-alkyl phosphonic acids. Synthesis 1994, 1272-1274.
107. Kitamura, M.; Yoshimura, M.; Tsukamoto, M.; Noyori, R. Synthesis of α-amino phosphonic acids by asymmetric hydrogenation. Enantiomer 1996, 1, 281-303.
108. Schöllkopf, U.; Hoppe, I.; Thiele, A. Enantioselective synthesis of L-(1-aminoethyl)phosphonic acid by asymmetric catalytic hydrogenation of N-[1-(dimethoxy-phosphoryl)ethenyl]formamide. Liebigs Ann. Chem. 1985, 555-559.
109. Atherton, F. R.; Hall, M. J.; Hassall, C. H.; Lambert, R. W.; Ringrose, P. S. Phosphonopeptides as antibacterial agents: rationale, chemistry, and structure-activity relationships. Antimicrob. Agents Chemother. 1979, 15, 677-683.
110. Kafarski, P.; Lejczak, B.; Szewczyk, J. Optically active 1-aminoalkanephosphonic acids. Dibenzoyl-L-tartaric anhydride as an effective agent for the resolution of racemic diphenyl 1-aminoalkanephosphonates. Can. J. Chem. 1983, 61, 2425-2030.
111. Kowalik, J.; Zygmunt, J.; Mastalerz, P. Determination of absolute configuration of optically active 1-aminoalkanephosphonic acids by chemical correlations. Phosphorus Sulfur 1983, 18, 393-396.
112. Lejczak, B.; Kafarski, P.; Mastalerz, P. Chromatographic assigment of the configuration of 1-aminoalkanephosphonic acids. J. Chromatogr. A 1985, 324, 455-461.
113. Solodenko, V. A.; Kasheva, T. N.; Kukhar, V. P.; Kozlova, E. V.; Mironenko, D. A.; Vedas, V. K. Preparation of optically active 1-aminoalkylphosphonic acids by stereoselective anzymatic hydrolysis of racemic N-acylated 1-aminoalkylphosphonic acids. Tetrahedron 1991, 47, 3989-3998.
114. Cowart, M.; Kowaluk, E. A.; Kohlhaas, K. L.; Alexander, K. M.; Kerwin, Jr. J. F. Synthesis of phosphorus-containing amino acid analogs as inhibitors of nitric oxide synthase. Bioorg. Med. Chem. Lett. 1996, 6, 999-1002.
115. Wang, C.-L. J.; Taylor, T. L.; Mical, A. J.; Spitz, S.; Reilly, T. M. Synthesis of phosphonopeptides as thrombin inhibitors. Tetrahedron Lett. 1992, 33, 7667-7670.
116. Joossens, J.; Van der Veken, P.; Lambeir, A.-M.; Augustyns, K.; Haemers, A. Development of irreversible diphenyl phosphonate inhibitors for urokinase plasminogen activator. J. Med. Chem. 2004, 47, 2411-2413.
117. Sosnovsky, G.; Lukszo, J.; Gravela, E.; Zuretti, M. F. In the search for new anticancer drugs. 13. Phosphonic and phosphinic analogues of ornithine. J. Med. Chem. 1985, 28, 1350-1354.
118. Hamilton, R.; Walker, B. J.; Walker, B. A convenient synthesis of N-protected diphenyl phosphonate ester analogues of ornithine, lysine and homolysine. Tetrahedron Lett. 1993, 34, 2847-2850.
119. Matczak-Jon, E.; Kurzak, B.; Sawka-Dobrowolska, W.; Lejczak, B.; Kafarski, P. Zinc (II) complexes of phosphonic acid analogues of aspartic acid and asparagine. J. Chem. Soc., Dalton Trans. 1998, 161-169.
120. Matczak-Jon, E.; Kurzak, B.; Sawka-Dobrowolska, W.; Kafarski, P.; Lejczak, B. Zinc (II) complexes of phosphonic acid analogues of glutamic acid. J. Chem. Soc., Dalton Trans. 1996, 3455-3464.
121. Obojska, A.; Lejczak, B. Utilisation of structurally diverse organophosphonates by Streptomycetes. Appl. Microbiol. Biotechnol. 2003, 62, 557-563.
122. Klimeck-Ochab, M.; Obojska, A.; Lejczak, B.; Picco, A. N. Isolation and characterization of two new microbial strains capable of degradation of the naturally occurring organophosphonate-ciliatine. Biodegradation 2007, 18, 223-231.
123. Vasella, A.; Voeffray, R. Asymmetric synthesis of α-aminophosphonic acids by cycloaddition of N-glycosyl-C-dialkoxyphosphonoylnitrones. Helv. Chim. Acta 1982, 65, 1953-1964.
124. Campell, M. M.; Carruthers, N. I.; Mickel, S. J. Aminophosphonic and aminophosphinic acid analogues of aspartic acid. Tetrahedron 1982, 38, 2513-2524.
125. Campell, M. M.; Carruthers, N. I. Synthesis of α-aminophosphonic and α-aminophosphinic acids and derived dipeptides from 4-acetoxyazetidin-2-ones. J. Chem. Soc., Chem. Commun. 1980, 730-731.
126. Hamilton, R.; Walker, B.; Walker, B. J. Synthesis and proteinase inhibitory properties of diphenyl phosphonate analogues of aspartic and glutamic acids. Bioorg. Med. Chem. Lett. 1998, 9, 1655-1660.
127. Kafarski, P.; Lejczak, B.; Mastalerz, P.; Du, D.; Radzikowski, C. N-(Phosphonoacetyl)amino phosphonates. Phosphonate analogues of N (phosphonoacetyl)-L-aspartic acid (PALA). J. Med. Chem. 1995, 28, 1555-1558.
128. Lejczak, B.; Popiel de Choszczak, M.; Kafarski, P. Inhibition of aminopeptidases by phosphonic acid and phosphinic acid analogues of aspartic and glutamic acids. J. Enzyme Inhib. Med. Chem. 1993, 7, 97-103.
129. Miliszkiewicz, D.; Wieczorek, P.; Lejczak, B.; Kowalik, E.; Kafarski, P. Herbicidal activity of phosphonic and phosphinic acid analogues of glutamic and aspartic acids. Pestic. Sci. 1992, 34, 349-354.
130. Kiss, T.; Farkas, E. Complexes of aminophosphonates. II. Transition metal complexes of aminophosphonic acid analogues of aspartic acid and glutamic acid. Inorg. Chim. Acta 1989, 155, 281-287.
131. Kudzin, Z. H. Phosphonocysteine and phosphonohomocysteine; synthesis and isolation. Synthesis 1983, 812-813.
132. Zygmunt, J. Aziridine-2-phosphonic acid, the valuable synthon for synthesis of 1-amino-2-functionalized ethanephosphonic acids. Tetrahedron 1985, 41, 4979-4982.
133. Kowalik, J.; Zygmunt, J.; Mastalerz, P. 1-Amino-2-mercaptoethanephosphonic acid, the phosphonic analog of cysteine. Pol. J. Chem. 1981, 55, 713-715.
134. Dolence, E. K.; Roylance, J. B. Optically active diethyl N-(ptoluenesulfonyl)-aziridine-2-phosphonates as chiral synthons for the synthesis of γ-substituted ω-aminophosphonates. Tetrahedron: Asymmetry 2004, 15, 3307-3322.
135. Lejczak, B.; Starzemska, H.; Mastalerz, P. Inhibition of rat liver glutamine synthetase by phosphonic analogues of glutamic acid. Experientia 1981, 37, 461-462.
136. Diel, P. J.; Maier, L. Organische phosphorverbindungen 79 herstellung und eigenschaften von ω-amino-carboxyalkylphosphon-und-phosphinsäuren. Phosphorus Sulfur 1987, 29, 201-209.
137. Vazeux, G.; Iturrioz, X.; Corvol, P.; Llorens-Cortès, C. A tyrosine residue essential for catalytic activity in aminopeptidase A. Biochem. J. 1997, 327, 883-889.
138. Smith, III, A. B.; Yager, K. M.; Taylor, C. M. Enantioselective synthesis of diverse ω-aminophosphonate diesters. J. Am. Chem. Soc. 1995, 117, 10879-10888.
139. Jászay, Z. M.; Németh, G.; Pham, T. S.; Petneházy, I.; Grün, A.; Tγke, L. Catalytic enantioselective Michael addition in the synthesis of ω-aminophosphonates. Tetrahedron: Asymmetry 2005, 16, 3837-3840.
140. For the catalytic enantioselective synthesis of ω-aminophosphonates from 92, see: Baldwin, I. C.; Williams, J. M. J.; Beckett, R. P. ω-Aminophosphonate derivatives as nucleophiles in diastereoselective and enantioselective palladium catalysed allylic substitution reactions. Tetrahedron: Asymmetry 1995, 6, 679-682.
141. Antczak, K.; Szewczyk, J. Separation of racemic phosphonic analogues of glutamic acid. Phosphorus Sulfur 1985, 22, 247-251.
142. For the synthesis of 100, see: Oleksyszyn, J.; Gruszecka, E.; Kafarski, P.; Mastalerz, P. New phosphonic analogs of aspartic and glutamic acid by aminoalkylation of trivalent phosphorus chlorides with ethyl acetyloacetate or ethyl levulinate and benzyl carbamate. Monatsh. Chem. 1982, 113, 59-71.
143. Hernandez, D.; Phillips, A. T.; Zon, J. 1-Amino-2-imidazol-4'-ylethylphosphonic acid is a potent reversible inhibitor of Pseudomonas putida histidine ammonia-lyase. Biochem. Mol. Biol. Int. 1994, 32, 189-194.
144. Wu, Y. Y.-L.; Tishler, M. ω-Amino-(4-imidazoil)-ethylphosphonic acid, the phosphonoisostere of histidine. Chin. Chem. Lett. 1991, 2, 95-98.
145. Ösapay, G.; Csiba, A. Inhibitory effect of synthetic aminophosphonic acid derivatives on human carbonic anhydrase. Eur. J. Med. Chem. 1993, 28, 355-361.
146. Cunningham, E.; Drag, M.; Kafarski, P.; Bell, A. Chemical target validation studies of aminopeptidase in malaria parasites using ω-aminoalkylphosphonate and phosphonopeptide inhibitors. Antimicrob. Agents Chemother. 2008, 52, 3221-3228.
147. Hammerschmidt, F.; Wuggenig, F. Enzymes in organic chemistry. Part 9: chemo-enzymatic synthesis of phosphonic acid analogues of L-valine, Lleucine, L-isoleucine, L-methionine and L-ω-aminobutyric acid of high enantiomeric excess. Tetrahedron: Asymmetry 1999, 10, 1709-1721.
148. Drescher, M.; Li, Y.-F.; Hammerschmidt, F. Enzymes in organic chemistry, part 2: lipase-catalysed hydrolysis of 1-acyloxy-2-aryethylphosphonates and synthesis of phosphonic acid analogues of L-phenylalanine and L-tyrosine. Tetrahedron 1995, 51, 4933-4946.
149. Mitsunobu, O. The use of diethyl azodicarboxylate and triphenylphosphine in synthesis and transformation of natural products. Synthesis 1981, 1-28.
150. Castro, B. R. Replacement of alcoholic hydroxyl groups by halogens and other nucleophiles via oxyphosphonium intermediates. Org. React. 1983, 29, 1-162.
151. Hughess, D. L. The Mitsunobu reaction. Org. React. 1992, 42, 335-356.
152. Hughess, D. L. Progress in the Mitsunobu reaction. A review. Org. Prep. Proced. Int. 1996, 28, 127-164.
153. Dodge, J. A.; Jones, S. A. Advances in the Mitsunobu reaction for the stereochemical inversion of hindered secondary alcohols. Rec. Res. Dev. Org. Chem. 1997, 1, 273-283.
154. Dembinski, R. Recent advances in the Mitsunobu reaction: modified reagents and the quest for chromatography-free separation. Eur. J. Org. Chem. 2004, 2763-2772.
155. Dandapani, S.; Curran, D. P. Fluorous Mitsunobu reagents and reactions. Tetrahedron 2002, 58, 3855-3864.
156. Lipshutz, B. H.; Chung, D. W.; Rich, B.; Corral, R. Simplification of the Mitsunobu reaction. Di-p-chlorobenzyl azodicarboxylate: a new azodicarboxylate. Org. Lett. 2006, 8, 5069-5072.
157. For the synthesis of non-chiral ω-aminophosphonates from ω-hydroxyphosphonates under solvent-free conditions using microwave irradiation, see: Kaboudin, B. A convenient synthesis of 1-aminophosphonates from 1-hydroxyphosphonates. Tetrahedron Lett. 2003, 44, 1051-1053.
158. Drαg, M.; Grembecka, J.; Paweαczak, M.; Kafarski, P. ω-Aminoalkylphosphonates as a tool in experimental optimisation of P1 side chain shape of potential inhibitors in S1 pocket of leucine-and neutral aminopeptidases. Eur. J. Med. Chem. 2005, 40, 764-771.
159. Stamper, C.; Bennett, B.; Edwards, T.; Holz, R. C.; Ringe, D.; Petsko, G. Inhibition of the aminopeptidase from Aeromonas proteolytica by L-leucinephosphonic acid. Spectroscopic and crystallographic characterization of the transition state of peptide hydrolysis. Biochemistry 2001, 40, 7035-7046.
160. Emgenbroich, M.; Wulff, G. A new enzyme model for enantioselective esterases based on molecularly imprinted polymers. Chem. Eur. J. 2003, 9, 4106-4117.
161. Grembecka, J.; Mucha, A.; Cierpicki, T.; Kafarski, P. The most potent organophosphorus inhibitors of leucine aminopeptidase. Structure-based design, chemistry, and activity. J. Med. Chem. 2003, 46, 2641-2655.
162. Bennett, B.; Holz, R. C. Inhibition of the aminopeptidase from Aeromonas proteolytica by L-leucinephosphonic acid, a transition state analogue of peptide hydrolysis. J. Am. Chem. Soc. 1998, 120, 12139-12140.
163. Hamilton, R.; Walker, B.; Walker, B. J. A highly convenient route to optically pure ω-aminophosphonic acids. Tetrahedron Lett. 1995, 36, 4451-4454.
164. Drag, M.; Grembecka, J.; Kafarski, P. The computer-aided design, synthesis, and activity prediction of new leucine aminopeptidase inhibitors. Phosphorus, Sulfur Silicon Relat. Elem. 2002, 177, 1591-1595.
165. Joly, G. D.; Jacobsen, E. N. Thiourea-catalyzed enantioselective hydrophosphonylation of imines: practical access to enantiomerically enriched ω-amino phosphonic acids. J. Am. Chem. Soc. 2004, 126, 4102-4103.
166. Yokomatsu, T.; Shibuya, S. Enantioselective synthesis of ω-aminophosphonic acids by an application of stereoselective opening of homochiral dioxane acetals with triethyl phosphite. Tetrahedron: Asymmetry 1992, 3, 377-378.
167. Jackson, D. S.; Fraser, S. A.; Ni, L.-M.; Kam, C.-M.; Winkler, U.; Johnson, D. A.; Froelich, C. J.; Hudig, D.; Powers, J. C. Synthesis and evaluation of diphenyl phosphonate esters as inhibitors of the trypsin-like granzymes A and K and mast cell tryptase. J. Med. Chem. 1998, 41, 2289-2301.
168. Pan, Z.; Jeffery, D. A.; Chehade, K.; Beltman, J.; Clark, J. M.; Grothaus, P.; Bogyo, M.; Baruch, A. Development of activity-based probes for trypsinfamily serine proteases. Bioorg. Med. Chem. Lett. 2006, 16, 2882-2885.
169. Massa, M. A.; Pitzele, B. S.; Jerome, G. M.; Moore, W. M.; Manning, P. T.; Sikorski, J. A. Syntheses of new racemic N-(1-iminoethyl)phosphalysine derivatives as potential inhibitors of nitric oxide synthase. Heteroatom Chem. 2000, 11, 505-511.
170. Keith, B. E.; Campbell, C. D.; Dingwall, J. G. 1-Aminoalkylphosphonous acids. Part 1. Isosteres of the protein amino acids. J. Chem. Soc., Perkin Trans. 1 1984, 2845-2853.
171. Fastrez, J.; Jespers, L.; Lison, D.; Renard, M.; Sonveaux, E. Synthesis of new phosphonate inhibitors of serine proteases. Tetrahedron Lett. 1989, 30, 6861-6864.
172. For the synthesis of protected LysP, see: Sieβczyk, M.; Kliszczak, M.; Oleksyszyn, J. Synthesis of isocyanide derivatives of ω-aminoalkylphosphonate diphenyl esters. Tetrahedron Lett. 2006, 47, 4209-4211.
173. Lowther, W. T.; Zhang, Y.; Sampson, P. B.; Honek, J. F.; Matthews, B. W. Insights into the mechanism of Escherichia coli methionine aminopeptidase from the structural analysis of reaction products and phosphorus-based transition-state analogues. Biochemistry 1999, 38, 14810-14819.
174. Abuelyaman, A. S.; Jackson, D. S.; Hudig, D.; Woodard, S. L.; Powers, J. C. Synthesis and kinetic studies of diphenyl 1-(N-peptidylamino)alkanephosphonate esters and their biotinylated derivatives as inhibitors of serine proteases and probes for lymphocyte granzymes. Arch. Biochem. Biophys. 1997, 344, 271-280.
175. Abuelyaman, A. S.; Hudig, D.; Woodard, S. L.; Powers, J. C. Fluorescent derivatives of diphenyl[1-(Npeptidylamino) alkyl]phosphonate esters: synthesis and use in the inhibition and cellular localization of serine proteases. Bioconjugate Chem. 1994, 5, 400-405.
176. Oleksyszyn, J.; Powers, J. C. Irreversible inhibition of serine proteases by peptide derivatives of (ω-aminoalkyl)phosphonate diphenyl esters. Biochemistry 1991, 30, 485-493.
177. Steere, J. A.; Sampson, P. B.; Honek, J. F. Synthesis of an ω-aminophosphonate nucleoside as an inhibitor of S-adenosyl-L-homocysteine hydrolase. Bioorg. Med. Chem. Lett. 2002, 12, 457-460.
178. Huber, R.; Vasella, A. Nucleophilic additions to N-glycosylnitrones: asymmetric synthesis of N-hydroxy-ω-aminophosphonic and ω-aminophosphonic acids. Helv. Chim. Acta 1987, 70, 1461-1476.
179. Izbicka-Dimitrjevic, E.; Mastalerz, P.; Kochman, M. Dual effects of phenylalanine analogs on rabbit-muscle pyruvate kinase activity. Eur. J. Biochem. 1981, 114, 565-568.
180. Beers, S. A.; Schwender, C. F.; Loughney, D. A.; Malloy, E.; Demarest, K.; Jordan, J. Phosphatase inhibitors-III. Benzylaminophosphonic acids as potent inhibitors of human prostatic acid phosphatase. Bioorg. Med. Chem. 1996, 4, 1693-1701.
181. Maier, L. Organic phosphorus compounds. Synthesis and properties of 1-amino-2-arylethylphosphonic and phosphinic acids as well as phosphine oxides. Phosphorus Sulfur 1990, 53, 43-67.
182. Wagner, J.; Lerner, R. A.; Barbas, III, C. F. Synthesis of five enantiomerically pure haptens designed for in vitro evolution of antibodies with peptidase activity. Bioorg. Med. Chem. 1996, 4, 901-916.
183. McKittrick, B. A.; Stamford, A. W.; Weng, X.; Ma, K.; Chackalamannil, S.; Czarniecki, M.; Cleven, R. M.; Fawzi, A. B. Design and synthesis of phosphinic acids that triply inhibit endothelin converting enzyme, angiotensin converting enzyme and neutral endopeptidase 24.11. Bioorg. Med. Chem. Lett. 1996, 6, 1629-1634.
184. Camp, N. P.; Hawkins, P. C. D.; Hitchcock, P. B.; Gani, D. Synthesis of stereochemically defined phosphonamidate-containing peptides: inhibitors for the HIV-1 proteinase. Bioorg. Med. Chem. Lett. 1992, 2, 1047-1050.
185. Pawelczak, M.; Nowak, K.; Kafarski, P. Synthesis of phosphono dipeptides, inhibitors of cathepsin C. Phosphorus Sulfur 1998, 132, 65-71.
186. Okamoto, Y.; Takai, S.; Miyazaki, M. Chymase inhibitor suppresses adhesion formation in a hamster experimental model. Eur. J. Pharmacol. 2002, 435, 265-267.
187. De Lombaert, S.; Stamford, L. B.; Blanchard, L.; Tan, J.; Hoyer, D.; Diefenbacher, C. G.; Wei, D.; Wallace, E. M.; Moskal, M. A.; Paula Savage, P.; Jeng, A. Y. Potent non-peptidic dual inhibitors of endothelin-converting enzyme and neutral endopeptidase 24.11. Bioorg. Med. Chem. Lett. 1997, 7, 1059-1064.
188. Harwig, C. W.; Hoffman, T. Z.; Wentworth, A. D.; Janda, K. D. A one-pot multistep approach to γ-azidophosphonate and phosphonothioate diesters: key intermediates in the synthesis of haptens for the generation of antibody ligases. Bioorg. Med. Chem. Lett. 2000, 10, 915-918.
189. Nelson, V.; Mastalerz, P. Phosphorous-containing analogues of aspartame. J. Pharm. Sci. 1984, 73, 1844-1846.
190. For diastereoselectivity explication, see: Alfonsov, V. A.; McKenna, C. E.; Bayandina, E. V.; Kashemirov, B. A.; Yarmieva, L. N.; Punegova, L. N.; Kataeva, O. N. Stereoselective synthesis of enantiopure cyclic γ-aminophosphonic acids: direct observation of inversion at phosphorus in phosphonate ester silyldealkylation by bromotrimethylsilane. Heteroatom. Chem. 2008, 19, 575-582.
191. Jacquier, R.; Lhassani, M.; Petrus, C.; Petrus, F. Asymmetric synthesis of 1-aminoalkylphosphonic acids. Phosphorus Sulfur 1993, 81, 83-87.
192. Sawamura, M.; Ito, Y.; Hayashi, T. Asymmetric synthesis of (1-aminoalkyl)phosphonic acids via asymmetric aldol reaction of (isocyanomethyl) phosphonates catalyzed by a chiral ferrocenyl-phosphine-gold(I) complex. Tetrahedron Lett. 1989, 30, 2247-2250.
193. Wagner, J.; Lerner, R. A.; Barbas, III, C. F. Synthesis of five enantiomerically pure haptens designed for in vitro evolution of antibodies with peptidase activity. Bioorg. Med. Chem. 1996, 4, 901-916.
194. Kowalik, J.; Sawka-Dobrowolska, W.; Gβowiak, T. Synthesis, molecular structure, and absolute configuration of an optically active (1-amino-2-phenylethyl)phosphonic acid monohydrate. J. Chem. Soc., Chem. Commun. 1984, 446-447.
195. Oleksyszyn, J.; Subotkowska, L.; Mastalerz, P. Diphenyl 1-aminoalkanephosphonates. Synthesis 1979, 985-986.
196. Dinér, P.; Amedjkouh, M. Aminophosphonates as organocatalysts in the direct asymmetric aldol reaction: towards syn selectivity in the presence of Lewis bases. Org. Biomol. Chem. 2006, 4, 2091-2096.
197. Chen, G.; Wang, Z.; Ding, K. Asymmetric conjugate addition of unmodified cyclic ketones to nitroolefins using aminophosphonate as the organocatalyst. Chin. J. Chem. 2009, 27, 163-168.
198. Tao, Q.; Tang, G.; Lin, K.; Zhao, Y.-F. γ-Aminophosphonates as novel organocatalysts for asymmetric Michael addition of carbonyl compounds to nitroolefins. Chirality 2008, 20, 833-838.
199. Malmgren, M.; Granander, J.; Amedjkouh, M. Asymmetric conjugate addition of nitroalkanes to enones with a chiral γ-aminophosphonate catalyst. Tetrahedron: Asymmetry 2008, 19, 1934-1940.
200. Rao, H.; Fu, H.; Jiang, Y.; Zhao, Y. Copper-catalyzed arylation of amines using diphenyl pyrrolidine-2-phosphonate as the new ligand. J. Org. Chem. 2005, 70, 8107-8109.
201. Gilmore, B. F.; Lynas, J. F.; Scott, C. J.; McGooham, C.; Martin, L.; Walker, B. Dipeptide proline diphenyl phosphonates are potent, irreversible inhibitors of seprase (FAPγ). Biochem. Biophys. Res. Commun. 2006, 346, 436-446.
202. Sesten, K.; Danils, L.; Van der Veken, P.; De Meester, I.; Lambeir, A.-M.; Sharpe, S.; Haemers, A.; Augustyns, K. Rapid parallel synthesis of dipeptide diphenyl phosphonate esters as inhibitors of dipeptidyl peptidases. J. Comb. Chem. 2003, 5, 336-344.
203. Belyaev, A.; Zhang, X.; Augustyns, K.; Lambeir, A.-M.; De Meester, I.; Vedernikova, I.; Sharpe, S.; Haemers, A. Structure-activity relationship of diaryl phosphonate esters as potent irreversible dipeptidyl peptidase IV inhibitors. J. Med. Chem. 1999, 42, 1041-1050.
204. De Meester, I.; Belyaev, A.; Lambeir, A.-M.; De Meyer, G. R. Y.; Van Osselaer, N.; Haemers, A.; Sharpe, S. In vivo inhibition of dipeptidyl peptidase IV activity by pro-pro-diphenylphosphonate (prodipine). Biochem. Pharm. 1997, 54, 173-179.
205. Boduszek, B.; Oleksyszyn, J.; Kam, C.-M.; Selzler, J.; Smith, R. E.; Powers, J. C. Dipeptide phosphonates as inhibitors of dipeptidyl peptidase IV. J. Med. Chem. 1994, 37, 3969-3976.
206. Petrillo, Jr., E. W.; Spitzmiller, E. R. Synthesis of 2-phosphonopyrrolidine and its substitution for proline in an inhibitor of angiotensin-converting enzyme. Tetrahedron Lett. 1979, 4929-4930.
207. Almquist, R. G.; Chao, W.-R.; Jennings-White, C. Synthesis and biological activity of carboxylic acid replacement analogues of the potent angiotensin converting enzyme inhibitor 5(S)-benzamido-4-oxo-6-phenylhexanoyl-L-proline. J. Med. Chem. 1985, 28, 1067-1071.
208. Robinson, R. A synthesis of tropinone. J. Chem. Soc. 1917, 111, 762-768.
209. Schopf, C. Die synthese von naturstoffen, insbesondere von alkaloiden, unter physiolo-gischen. Angew. Chem. 1937, 50, 779-787.
210. Stevens, R. V.; Lee, A. W. M. Stereochemistry of the Robinson-Schoepf reaction. A stereospecific total synthesis of the ladybug defense alkaloids precoccinelline and coccinelline. J. Am. Chem. Soc. 1979, 101, 7032-7035.
211. Bonin, M.; Grierson, D. S.; Royer, J.; Husson H.-P. A stable chiral 1,4-dihydropyridine equivalent for the asymmetric synthesis of substituted piperidines: 2-cyano-6-phenyl-oxazolopiperidine. Org. Synth. Coll. 1998, 9, 176-180.
212. Katritzky, A. R.; Cui, X.-L.; Yang, B.; Steel, P. J. Asymmetric syntheses of 2-substituted and 2,5-disubstituted pyrrolidines from (3S,5R,7aR)-5-(benzotriazol-1-yl)-3-phenyl[2,1-b]oxazolopyrrolidine. J. Org. Chem. 1999, 64, 1979-1985.
213. Kaname, M.; Arakawa, Y.; Yoshifuji, S. Synthesis of novel (R)-and (S)-piperidazine-3-phosphonic acids and transformation into (R)-and (S)-pyrrolidine-2-phosphonic acids. Tetrahedron Lett. 2001, 42, 2713-2716.
214. Biraboneye, A. C.; Madonna, S.; Laras, Y.; Krantic, S.; Maher, P.; Kraus, J.-L. Potential neuroprotective drugs in cerebral ischemia: new saturated and polyunsaturated lipids coupled to hydrophilic moieties: synthesis and biological activity. J. Med. Chem. 2009, 52, 4358-4369.
215. Cook, S. P.; Galve-Roperh, I.; Martínez del Pozo, A.; Rodríguez-Crespos, I. Direct calcium binding results in activation of brain serine racemase. J. Biol. Chem. 2002, 277, 27782-27792.
216. Hammerschmidt, F.; Völlenkle, H. Absolute konfiguration der (2-amino-1-hydroxyethyl) phosphon-säure aus Acanthamoeba castellanii (Neff)-darstellung der phosphonsäure-analoga von (+)-und (-)-serin. Liebigs Ann. Chem. 1989, 577-583.
217. Hammerschmidt, F.; Lindner, W.; Wuggenig, F.; Zarbl, E. Enzymes in organic chemistry. Part 10: chemo-enzymatic synthesis of L-phosphaserine and L-phosphaisoserine and enantioseparation of aminohydroxyethylphosphonic acids by non-aqueous capillary electrophoresis with quinine carbamate as chiral ion pair agent. Tetrahedron: Asymmetry 2000, 11, 2955-2964.
218. Seebach, D.; Aebi, J. D. γ-Alkylation of serine with self-reproduction of the center of chirality. Tetrahedron Lett. 1984, 25, 2545-2548.
219. Renaud, P.; Seebach, D. Preparation of chiral building blocks from amino acids and peptides via electrolytic decarboxylation and TiCl4-induced aminoalkylation. Angew. Chem. Int. Ed. Engl. 1986, 25, 843-844.
220. Lejczak, B.; Kafarski, P.; Soroka, M.; Mastalerz, P. Synthesis of the phosphonic acid analog of serine. Synthesis 1984, 577-580.
221. Bongini, A.; Camerini, R.; Panunzio, M. Efficient synthesis of the four diastereomers of phosphothreonine from lactaldehyde. Tetrahedron: Asymmetry 1996, 7, 1467-1476.
222. Bongini, A.; Camerini, R.; Hofman, S.; Panunzio, M. Synthesis of (1S,2S)-phosphothreonine via Ntrimethylsilylimine of (S)-lactic aldehyde. Tetrahedron Lett. 1994, 35, 8045-8048.
223. Kitamura, M.; Tokunaga, M.; Pham, T.; Lubell, W. D.; Noyori, R. Asymmetric synthesis of γ-amino α-hydroxy phosphonic acids via BINAP-ruthenium catalyzed hydrogenation. Tetrahedron Lett. 1995, 36, 5769-5772.
224. Seebach, D.; Charczuk, R.; Geber, C.; Renaud, P.; Berner, H.; Schneider, H. 50. Elektrochemische decarboxylierung von L-threonin-und oligopeptidderivaten unter bildung von N-acyl-N, O-acetalen: herstellung von oligopeptiden mit carboxamid-oder phosphonat-C-terminus. Helv. Chim. Acta 1989, 72, 401-425.
225. Agamennone, M.; Campestre, C.; Preziuso, S.; Consalvi, V.; Crucianelli, M.; Mazza, F.; Politi, V.; Ragno, R.; Tortorella, P.; Gallina, C. Synthesis and evaluation of new tripeptide phosphonate inhibitors of MMP-8 and MMP-2. Eur. J. Med. Chem. 2005, 40, 271-279.
226. Aschi, M.; Roccatano, D.; Di Nola, A.; Gallina, C.; Gavuzzo, E.; Pochetti, G.; Pieper, M.; Tschesche, H.; Mazza, F. Computational study of the catalytic domain of human neutrophil collagenase. Specific role of the S3 and S'3 subsites in the interaction with a phosphonate inhibitor. J. Comput.-Aided Mol. Des. 2002, 16, 213-225.
227. D'Alessio, S.; Gallina, C.; Gavuzzo, E.; Giordano, C.; Gorini, B.; Mazza, F.; Paradisi, M. P.; Panini, G.; Pochetti, G.; Sella, A. Inhibition of adamalysin II and MMPs by phosphonate analogues of snake venom peptides. Bioorg. Med. Chem. Lett. 1999, 7, 389-394.
228. Gavuzzo, E.; Pochetti, G.; Mazza, F.; Gallina, C.; Gorini, B.; D'Alessio, S.; Pieper, M.; Tschesche, H.; Tucker, P. A. Two crystal structures of human neutrophil collagenase, one complexed with a primed-and the other with an unprimed-side inhibitor: implications for drug design. J. Med. Chem. 2000, 43, 3377-3385.
229. Rogers, R. S.; Sterm, M. K. An improved synthesis of the phosphonic acid analog of tryptophan. Synlett 1992, 708-708.
230. Chen, S. F.; Kumar, S. D.; Tishler, M. The synthesis of D, L-phosphotryptophan. Tetrahedron Lett. 1983, 24, 5461-5464.
231. Subotkowski, W.; Kowalik, J.; Tyka, R.; Mastalerz, P. The phosphonic analog of tryptophan. Pol. J. Chem. 1981, 55, 853-857.
232. Kido, Y.; Hamakado, T.; Anno, M.; Miyagawa, E.; Motoki, Y.; Wakamiya, T.; Shiba, T. Isolation and characterization of I5B2, a new phosphorus containing inhibitor of angiotensin I converting enzyme produced by Actinomadura sp. J. Antibiot. 1984, 37, 965-969.
233. Ntai, I.; Bachmann, B. O. Identification of ACE pharmacophore in the phosphonopeptide metabolite K-26. Bioorg. Med. Chem. Lett. 2008, 18, 3068-3071.
234. Ntai, I.; Vanessa V. Phelan, V. V.; Bachmann, B. O. Phosphonopeptide K-26 biosynthetic intermediates in Astrosporangium hypotensionis. Chem. Commun. 2006, 4518-4520.
235. Yamato, M.; Koguchi, T.; Okachi, R.; Yamada, K.; Nakayama, K.; Kase, H.; Karasawa, A.; Shuto, K. K-26, a novel inhibitor of angiotensin I converting enzyme produced by an actinomycete K-26. J. Antibiot. 1986, 39, 44-52.
236. Hirayama, N.; Kasai, M.; Shirahata, K. Structure and conformation of a novel inhibitor of angiotensin I converting enzyme: a tripeptide containing phosphonic acid. Int. J. Pept. Prot. Res. 1991, 38, 20-24.
237. Kowalik, J.; Zygmunt, J.; Mastalerz, P. Determination of absolute configuration of optically active 1-aminoalkanephosphonic acids by chemical correlations. Phosphorus Sulfur 1983, 18, 393-396.
238. Koguchi, T.; Yamada, K.; Yamoto, M.; Okachi, R.; Nakayama, K.; Kase, K. K-4, a novel inhibitor of angiotensin I converting enzyme produced by Actinomadura spiculosospora. J. Antibiot. 1986, 39, 364-371.
239. Lejczak, B.; Kafarski, P.; Makowiecka, E. Phosphonic analogues of tyrosine and 3,4-dihydroxyphenylalanine (dopa) influence mushroom tyrosinase activity. Biochem. J. 1987, 242, 81-88.
240. Cassaigne, A.; Lacoste, A. M.; Neuzil, E. Recherches sur les acides aminoalkylphosphoniques. I. Action de la tyrosinase sur l'analogue phosphonique de la tyrosine. Bull. Soc. Chim. Biol. 1967, 49, 1813-1825.
241. Faleev, N. G.; Zhukov, Y. N.; Khurs, E. N.; Gogoleva, O. I.; Barbolina, M. V.; Bazhulina, N. P.; Belikov, V. M.; Demidkina, T. V.; Khomutov, R. D. Interaction of tyrosine phenol-lyase with phosphoro-organic analogues of substrate amino acids. Eur. J. Biochem. 2000, 267, 6897-6902.
242. Khomutov, R. M.; Faleev, N. G.; Belyankin, A. V.; Khurs, E. N.; Khomutov, A. R.; Peryshkova, O. E.; Belikov, V. M. 1-Amino-2-(4-hydroxyphenyl) ethyl phosphinic acid: a novel substrate of tyrosine phenol-lyase. Bioorg. Khim. (Russ.) 1997, 23, 919-921.
243. Biasone, A.; Tortorella, P.; Campestre, C.; Agamennone, M.; Preziuso, S.; Chiappini, M.; Nuti, E.; Carelli, P.; Rossello, A.; Mazza, F.; Gallina, C. α-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs. Bioorg. Med. Chem. 2007, 15, 791-799.
244. Pochetti, G.; Gavuzzo, E.; Campestre, C.; Agamennone, M.; Tortorella, P.; Consalvi, V.; Gallina, C.; Hiller, O.; Tschesche, H.; Tucker, P. A.; Mazza, F. Structural insight into the stereoselective inhibition of MMP-8 by enantiomeric sulfonamide phosphonates. J. Med. Chem. 2006, 49, 923-931.
245. Gαowiak, T.; Sawka-Dobrowolska, W.; Kowalik, J.; Mastalerz, P.; Soroka, M.; Zoα, J. Absolute configuration of optically active aminophosphonic acids. Tetrahedron Lett. 1977, 45, 3965-3968.
246. Sasai, H.; Arai, S.; Tahara, Y.; Shibasaki, M. Catalytic Asymmetric Synthesis of α-aminophosphonates using lanthanoid-potassium-BINOL complexes. J. Org. Chem. 1995, 60, 6656-6657.